Genetic Testing: Scientific Background for Policymakers

Genetic Testing: Scientific Background for Policymakers

Date: February 20, 2014
Creator: Sarata, Amanda K.
Description: This report discusses bills addressing genetic discrimination in health insurance and employment; personalized medicine; the patenting of genetic material; and the oversight of clinical laboratory tests (in vitro diagnostics), including genetic tests.
Contributing Partner: UNT Libraries Government Documents Department
Treating Ebola Patients in the United States: Health Care Delivery Implications

Treating Ebola Patients in the United States: Health Care Delivery Implications

Date: November 4, 2014
Creator: Sarata, Amanda K.
Description: This report discusses the recent response to Ebola patients in the United States. While the U.S. health care system has the resources to effectively identify and treat Ebola cases, a situation that is novel, emergent, and resource-intensive may test the system's ability to effectively mobilize those resources.
Contributing Partner: UNT Libraries Government Documents Department
The Genetic Information Nondiscrimination Act of 2008 (GINA)

The Genetic Information Nondiscrimination Act of 2008 (GINA)

Date: July 9, 2008
Creator: Jones, Nancy Lee & Sarata, Amanda K.
Description: This report provides background on genetic information, legal implications regarding the use of this information, and relevant laws. It also discusses the statutory provisions of the Genetic Information Nondiscrimination Act of 2008 (GINA).
Contributing Partner: UNT Libraries Government Documents Department
Discretionary Spending Under the Affordable Care Act (ACA)

Discretionary Spending Under the Affordable Care Act (ACA)

Date: October 28, 2014
Creator: Redhead, C. Stephen; Colello, Kirsten J.; Heisler, Elayne J.; Lister, Sarah A. & Sarata, Amanda K.
Description: The Patient Protection and Affordable Care Act (Affordable Care Act, or ACA) reauthorized funding for numerous existing discretionary grant programs administered by the Department of Health and Human Services (HHS). The ACA also created many new discretionary grant programs and provided for each an authorization of appropriations. Generally, the law authorized (or reauthorized) appropriations through FY2014 or FY2015. This report summarizes all the discretionary spending provisions in the ACA.
Contributing Partner: UNT Libraries Government Documents Department
The Food and Drug Administration Safety and Innovation Act (P.L. 112-144)

The Food and Drug Administration Safety and Innovation Act (P.L. 112-144)

Date: August 21, 2012
Creator: Thaul, Susan; Bagalman, Erin; Corby-Edwards, Amalia K.; Glassgold, Judith M.; Johnson, Judith A.; Lister, Sarah A. et al.
Description: This report provides a brief policy background narrative and an overview of provisions for each title of the Food and Drug Administration Safety and Innovation Act (FDASIA), P.L. 112-144. The legislation amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand the authority of the Food and Drug Administration (FDA) in performing its human drug, biological product, and medical device responsibilities.
Contributing Partner: UNT Libraries Government Documents Department